| Serial Number | 99545865 |
| Word Mark | GEM-DIMER |
| Filing Date | Friday, December 12, 2025 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, June 9, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 9, 2026 |
| Goods and Services | Pharmaceutical preparations comprising of monospecific, bispecific, or multi-specific antibody based molecules for the treatment of human diseases, namely, autoimmune, inflammatory, oncologic and neoplastic, infectious, cardiovascular, metabolic, endocrine, respiratory, musculoskeletal, neuromuscular, neurologic, mental health, dermatologic, ophthalmologic, hematologic, renal, gastrointestinal and digestive system, urogenital, reproductive, pediatric and developmental, neurodevelopmental, genetic, rare, namely, chronic, progressive, and life-threatening, and orphan diseases and disorders, conditions related to transplantation and tolerance, and immune mediated conditions; pharmaceutical agents comprising of monospecific, bispecific, or multi-specific antibody based molecules for the treatment of human diseases, namely, autoimmune, inflammatory, oncologic and neoplastic, infectious, cardiovascular, metabolic, endocrine, respiratory, musculoskeletal, neuromuscular, neurologic, mental health, dermatologic, ophthalmologic, hematologic, renal, gastrointestinal and digestive system, urogenital, reproductive, pediatric and developmental, neurodevelopmental, genetic, rare, namely, chronic, progressive, and life-threatening, and orphan diseases and disorders, conditions related to transplantation and tolerance, and immune mediated conditions; monospecific, bispecific, or multi-specific antibody based molecules as a component in pharmaceutical preparations for the treatment of human diseases, namely, autoimmune, inflammatory, oncologic and neoplastic, infectious, cardiovascular, metabolic, endocrine, respiratory, musculoskeletal, neuromuscular, neurologic, mental health, dermatologic, ophthalmologic, hematologic, renal, gastrointestinal and digestive system, urogenital, reproductive, pediatric and developmental, neurodevelopmental, genetic, rare, namely, chronic, progressive, and life-threatening, and orphan diseases and disorders, conditions related to transplantation and tolerance, and immune mediated conditions |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 12, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Hinge Bio, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Redwood City, CA 94065 US |
| Party Name | Hinge Bio, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Redwood City, CA 94065 US |
| Event Date | Event Description |
| Friday, December 12, 2025 | NEW APPLICATION ENTERED |
| Friday, December 12, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, December 12, 2025 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, February 10, 2026 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, February 10, 2026 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, February 10, 2026 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, April 16, 2026 | ASSIGNED TO EXAMINER |
| Thursday, April 16, 2026 | NON-FINAL ACTION WRITTEN |
| Thursday, April 16, 2026 | NON-FINAL ACTION E-MAILED |
| Thursday, April 16, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, April 29, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, April 29, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, April 29, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, May 11, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 3, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 9, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 9, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |